NEW YORK (GenomeWeb News) – Olink Bioscience today announced a consortium formed to advance research into inflammatory bowel diseases.

The Inflammatory Bowel Disease Characterization by a multi-modal integrated biomarker study Consortium was launched in December with a €6 million ($7.7 million) grant from the European Commission's 7th Framework Program. The effort will run through Nov. 30, 2016.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.